Ibandronate
Last Updated: 04/28/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1343 publications
Evaluation of compliance, persistence, safety profile and satisfaction to monthly single-pill treatment regimen of ibandronic acid 150 mg and cholecalciferol 22,400 IU among postmenopausal women with osteoporosis.
Journal: Current medical research and opinion
Published: March 25, 2026
A novel approach for discriminating lipophilic bisphosphonate-based pharmaceuticals using a potentiometric array.
Journal: Analytical methods : advancing methods and applications
Published: February 09, 2026
Expected change: a new concept for monitoring patients on oral bisphosphonates.
Journal: Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
Published: February 08, 2026
Evaluation of Osteonecrosis Risk Using Serum C-Terminal Cross-Linked Telopeptide of Type 1 Collagen (CTX-1) Levels in Osteoporotic Patients: Effects of Drug Holidays and Risk Factors.
Journal: The Eurasian journal of medicine
Published: January 15, 2026
Minimally Invasive Prophylactic Plating for Bisphosphonate-induced Atypical Femoral Fracture Post Total Hip Replacement.
Journal: Journal of orthopaedic case reports
Published: December 12, 2025
Cost-Effectiveness of Biosimilar Denosumab Versus Bisphosphonates in Postmenopausal Osteoporosis.
Journal: PharmacoEconomics - open
Published: October 02, 2025
Post-fracture care and predictors of anti-osteoporotic treatment in Switzerland: a nationwide health claims analysis.
Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
Published: September 19, 2025
Association of Osteoporosis and Bone-Strengthening Medications with Postoperative Outcomes Following Transforaminal Lumbar Interbody Fusion.
Journal: World neurosurgery
Published: September 15, 2025
Prescription Trends by Orthopedic Surgery Provider: Review of the Medicare Part D Prescribers - by Provider and Drug, 2013-2021.
Journal: Orthopedics
Published: August 11, 2025
Bisphosphonate-related ocular adverse events: a pharmacovigilance study based on the FAERS database.
Bisphosphonate-related ocular adverse events: a pharmacovigilance study based on the FAERS database.
Journal: Endocrine connections
Published: July 30, 2025
Systemic or local administration of bisphosphonate and the orthodontic tooth movement in animals: a systematic review.
Journal: European journal of orthodontics
Published: June 27, 2025
Last Updated: 04/28/2026